Showing results (1601-1610 of 1,815) with videos related to

Sort By:
Pageof 182
JACC. Cardiovascular Interventions|January 2, 2022
10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy CalcificationHideyuki Kawashima, Patrick W Serruys, Hironori Hara, et al.
Circulation|October 1, 1996
Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy. 30-day clinical outcome of the French Multicenter RegistryG J Karrillon, M C Morice, E Benveniste, et al.
ACS Nano|June 24, 2024
Theragnostic Gadolinium-Based Nanoparticles Safely Augment X-ray Radiation Effects in Patients with Cervical CancerCyrus Chargari, Pauline Maury, Matthieu Texier, et al.
Bone Marrow Transplantation|August 9, 2018
Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete responseM Hasib Sidiqi, Mohammed A Aljama, Dragan Jevremovic, et al.
International Journal of Cardiology|August 9, 2022
Geographic disparity in 10-year mortality after coronary artery revascularization in the SYNTAXES trialShigetaka Kageyama, Patrick W Serruys, Scot Garg, et al.
European Heart Journal|March 29, 2019
Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trialOri Ben-Yehuda, Shmuel Chen, Björn Redfors, et al.
Circulation|February 1, 1996
Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot StudyP W Serruys, H Emanuelsson, W van der Giessen, et al.
JACC. Cardiovascular Interventions|August 24, 2013
Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trialPatrick W Serruys, Vasim Farooq, Bindu Kalesan, et al.
Blood|September 12, 2022
Tγδ LGLL identifies a subset with more symptomatic disease: analysis of an international cohort of 137 patientsGregorio Barilà, Angela Grassi, HeeJin Cheon, et al.
Circulation. Cardiovascular Interventions|January 6, 2011
Value of age, creatinine, and ejection fraction (ACEF score) in assessing risk in patients undergoing percutaneous coronary interventions in the 'All-Comers' LEADERS trialJoanna J Wykrzykowska, Scot Garg, Yoshinobu Onuma, et al.
Pageof 182